Center for Clinical and Basic Research AS
- Registry code
- 10746218
- VAT number
- EE100684494
- Address
- Harju maakond, Tallinn, Kesklinna linnaosa, J. Pärna tn 4, 10128
- Registered
- 23.03.2001 · 25 yrs
- Activity
- Teadus- ja arendustegevus loodus- ja tehnikateaduste vallas 72101
- Capital
- 25 560 €
- i•••@n•••.euLog in to see
- Phone
- +372 •• ••••Log in to see
- Website
- www.nordestmedical.eu from email
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
2 persons
| Board 1 | ||
|---|---|---|
| Ivo Valter3 companiesno tax debt | Personal ID ↗ | 03.03.2025 |
| Other persons 1 | ||
| Nasdaq CSD SE1983 companies155 with tax debt40 bankruptShare register keeper | Personal ID ↗ | 27.09.2017 |
| Beneficial owners 2 | ||
| Ivo Valter3 companiesno tax debtmember of the senior management body, i.e. management or supervisory board member | 26.11.2021 | |
| Katrin Valter2 companiesno tax debtmember of the senior management body, i.e. management or supervisory board member | 26.11.2021 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 178 718 € | ▲ 70% | 42 209 € | 37 830 € | 17 |
| 2026 Q1 | 216 089 € | ▼ 29% | 44 098 € | 39 796 € | 17 |
| 2025 Q4 | 160 564 € | ▲ 2% | 45 796 € | 41 401 € | 17 |
| 2025 Q3 | 154 024 € | ▲ 0% | 45 068 € | 40 723 € | 17 |
| 2025 Q2 | 105 000 € | ▼ 73% | 43 816 € | 39 649 € | 16 |
| 2025 Q1 | 303 025 € | ▲ 51% | 43 363 € | 39 746 € | 16 |
| 2024 Q4 | 158 167 € | ▼ 20% | 43 229 € | 40 366 € | 16 |
| 2024 Q3 | 153 852 € | ▼ 24% | 42 960 € | 40 058 € | 16 |
| 2024 Q2 | 383 181 € | ▲ 79% | 44 829 € | 41 746 € | 16 |
| 2024 Q1 | 200 471 € | ▼ 26% | 44 536 € | 41 821 € | 15 |
| 2023 Q4 | 197 135 € | ▼ 10% | 42 379 € | 39 453 € | 15 |
| 2023 Q3 | 202 948 € | ▼ 0% | 43 963 € | 41 122 € | 14 |
Show full history (18 quarters)
| 2023 Q2 | 213 540 € | ▲ 88% | 39 719 € | 36 958 € | 14 |
| 2023 Q1 | 269 915 € | ▲ 114% | 43 477 € | 40 567 € | 14 |
| 2022 Q4 | 219 403 € | 40 083 € | 37 234 € | 18 | |
| 2022 Q3 | 203 934 € | 40 885 € | 37 867 € | 18 | |
| 2022 Q2 | 113 509 € | 36 271 € | 33 621 € | 17 | |
| 2022 Q1 | 126 288 € | 37 795 € | 35 444 € | 19 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
5 yr
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Sales revenue | 566 k € | ▼ 47% | 1,1 m € | ▲ 27% | 841 k € | ▲ 20% | 701 k € | ▲ 174% | 256 k € |
| Profit | -130 k € | ▼ into loss | 285 k € | ▲ 308% | 69 678 € | ▲ into profit | -27 826 € | ▲ 96% | -789 k € |
| Profit margin | -23,0% | 26,8% | 8,3% | -4,0% | -308,2% | ||||
| Retained earnings | 593 k € | ▲ 92% | 308 k € | ▲ 29% | 238 k € | ▼ 10% | 266 k € | ▼ 75% | 1,1 m € |
| Cash | 300 k € | ▲ 97% | 152 k € | ▲ 719% | 18 610 € | ▼ 87% | 143 k € | ▼ 26% | 192 k € |
| Current assets | 362 k € | ▼ 24% | 479 k € | ▲ 273% | 128 k € | ▼ 54% | 281 k € | ▼ 12% | 321 k € |
| Fixed assets | 149 k € | ▼ 8% | 162 k € | ▼ 30% | 233 k € | ▲ 16× | 14 204 € | ▲ 672% | 1 841 € |
| Assets | 511 k € | ▼ 20% | 641 k € | ▲ 77% | 362 k € | ▲ 22% | 295 k € | ▼ 8% | 323 k € |
| Current liabilities | 20 163 € | ▼ 1% | 20 454 € | ▼ 19% | 25 399 € | ▼ 12% | 28 875 € | ▲ 3% | 28 106 € |
| Long-term liabilities | — | — | — | — | 0 € | ||||
| Total liabilities | 20 163 € | ▼ 1% | 20 454 € | ▼ 19% | 25 399 € | ▼ 12% | 28 875 € | ▲ 3% | 28 106 € |
| Equity | 491 k € | ▼ 21% | 621 k € | ▲ 85% | 336 k € | ▲ 26% | 267 k € | ▼ 9% | 294 k € |
| Labour costs | -398 k € | ▼ 1% | -395 k € | ▼ 2% | -388 k € | ▼ 5% | -368 k € | ▼ 10% | -334 k € |
| Employees | 14 | ▼ 12% | 16 | 0% | 16 | ▲ 7% | 15 | ▲ 15% | 13 |
| Filed | 30.06.2026 | 30.06.2025 | 30.06.2024 | 30.06.2023 | 30.06.2022 | ||||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Teadus- ja arendustegevus loodus- ja tehnikateaduste vallas main activity | 72101 | 566 390 € | 100% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
60
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Teadus- ja arendustegevus loodus- ja tehnikateaduste vallas
20
| # | Company | Revenue |
|---|---|---|
| 1 | Starship Technologies OÜ | 22,2 m € |
| 2 | Diotech OÜ | 10,6 m € |
| 3 | Icosagen Cell Factory OÜ | 8,8 m € |
| 4 | Maaelu Teadmuskeskus | 4,9 m € |
| 5 | OÜ Kliiniliste Uuringute Keskus | 4,4 m € |
| 6 | OÜ Cambrex Tallinn | 3,4 m € |
| 7 | IQVIA RDS Estonia OÜ | 3,3 m € |
| 8 | Bisly OÜ | 3,3 m € |
| 9 | PSI CRO OSAÜHING | 3,1 m € |
| 10 | Attarat Holding OÜ | 2,6 m € |
| 11 | Icosagen AS | 2,1 m € |
| 12 | Futugrid Technologies OÜ | 2,0 m € |
| 13 | AuVe Tech OÜ | 1,9 m € |
| 14 | Sihtasutus Stockholmi Keskkonnainstituudi Tallinna Keskus | 1,7 m € |
| 15 | The J. Molner Company OÜ | 1,7 m € |
| 16 | GScan OÜ | 1,6 m € |
| 17 | Krakul OÜ | 1,5 m € |
| 18 | STACC OÜ | 1,5 m € |
| 19 | GeneMed OÜ | 1,4 m € |
| 20 | MTÜ AUSTRALO Alpha Lab | 1,3 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, domains
2 records
Activity licences (MTR and environmental)
| Field | Licence number | Valid from |
|---|---|---|
| Jäätmekäitleja registreering: Jäätmete taaskasutamine või kõrvaldamine - Pärna 4 jäätmekäitluskoht | RE.JÄ/520310 | 09.10.2023 kuni 31.12.2028 |
Domains
| Domain | Source |
|---|---|
| nordestmedical.eu |
History and notices
19
| Date | Type | Content |
|---|---|---|
| 03.03.2025 | Entry | Amendment entry |
| 27.02.2025 | Order to remedy deficiencies to correct non-entry data | Amendment entry |
| 30.06.2023 | Entry | Amendment entry |
| 27.01.2023 | Entry | Muutmiskanne ÄS § 525 lg 2 alusel |
| 30.06.2022 | Entry | Amendment entry |
| 17.02.2022 | Entry | Amendment entry |
| 16.02.2022 | Order to remedy deficiencies | Amendment entry |
| 28.01.2022 | Entry | Muutmiskanne ÄS § 525 lg 2 alusel |
| 15.01.2020 | Entry | Muutmiskanne ÄS § 525 lg 2 alusel |
| 08.05.2018 | Entry | Amendment entry |
| 17.01.2018 | Entry | Amendment entry |
| 07.11.2017 | Entry | Amendment entry |
| 27.09.2017 | Entry | Amendment entry |
| 14.01.2016 | Entry | Amendment entry |
| 03.12.2008 | Tegevusalade kustutamine registrikaardilt | Amendment entry |
| 23.03.2006 | Entry | Amendment entry |
| 03.12.2004 | Jaatav kandeotsus | Amendment entry |
| 19.08.2002 | Jaatav kandeotsus | Mitteavaldatav muutmiskanne |
| 03.04.2002 | Jaatav kandeotsus | Mitteavaldatav muutmiskanne |